Trials / Conditions / Recurrent Vaginal Carcinoma
Recurrent Vaginal Carcinoma
4 registered clinical trials studyying Recurrent Vaginal Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers NCT03968406 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating P NCT03439085 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Me NCT03452332 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |